Healthcare provider profile · identity verified

Kyle C Moylan, MD

Geriatric Medicine · SAINT LOUIS, MO · NPI 1124052808

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	835	232
Amlodipine Besylate	Amlodipine Besylate	571	168
Losartan Potassium	Losartan Potassium	550	166
Levothyroxine Sodium	Levothyroxine Sodium	487	128
Lisinopril	Lisinopril	382	104
Metformin Hcl	Metformin Hcl	329	92
Pantoprazole Sodium	Pantoprazole Sodium	297	94
Metoprolol Succinate	Metoprolol Succinate	285	75
Omeprazole	Omeprazole	283	83
Rosuvastatin Calcium	Rosuvastatin Calcium	259	78
Gabapentin	Gabapentin	243	80
Hydrochlorothiazide	Hydrochlorothiazide	225	64
Eliquis	Apixaban	206	47
Escitalopram Oxalate	Escitalopram Oxalate	197	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	30
Tamsulosin Hcl	Tamsulosin Hcl	187	63
Simvastatin	Simvastatin	184	44
Tramadol Hcl	Tramadol Hcl	168	31
Sertraline Hcl	Sertraline Hcl	167	42
Alprazolam	Alprazolam	156	55
Allopurinol	Allopurinol	153	42
Fluticasone Propionate	Fluticasone Propionate	145	54
Metoprolol Tartrate	Metoprolol Tartrate	142	36
Meloxicam	Meloxicam	129	39
Mirtazapine	Mirtazapine	128	29
Alendronate Sodium	Alendronate Sodium	127	36
Duloxetine Hcl	Duloxetine Hcl	121	39
Pravastatin Sodium	Pravastatin Sodium	121	34
Furosemide	Furosemide	119	47
Donepezil Hcl	Donepezil Hcl	116	26
Bupropion Xl	Bupropion Hcl	115	28
Trazodone Hcl	Trazodone Hcl	115	37
Carvedilol	Carvedilol	106	31
Famotidine	Famotidine	104	28
Zolpidem Tartrate	Zolpidem Tartrate	103	15
Montelukast Sodium	Montelukast Sodium	99	24
Quetiapine Fumarate	Quetiapine Fumarate	98	19
Glipizide	Glipizide	95	28
Albuterol Sulfate Hfa	Albuterol Sulfate	93	33
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	90	36
Potassium Chloride	Potassium Chloride	90	36
Spironolactone	Spironolactone	87	29
Lovastatin	Lovastatin	86	24
Ezetimibe	Ezetimibe	84	24
Venlafaxine Hcl Er	Venlafaxine Hcl	82	19
Ropinirole Hcl	Ropinirole Hcl	76	17
Citalopram Hbr	Citalopram Hydrobromide	74	20
Tizanidine Hcl	Tizanidine Hcl	73	31
Clopidogrel	Clopidogrel Bisulfate	68	20
Prednisone	Prednisone	68	35
Rybelsus	Semaglutide	63	suppressed
Finasteride	Finasteride	61	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	15
Oxybutynin Chloride Er	Oxybutynin Chloride	56	13
Arexvy	Rsvpref3 Antigen/As01e/Pf	55	55
Memantine Hcl	Memantine Hcl	55	13
Jardiance	Empagliflozin	52	12
Pioglitazone Hcl	Pioglitazone Hcl	52	15
Lorazepam	Lorazepam	51	17
Doxazosin Mesylate	Doxazosin Mesylate	50	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	suppressed
Glipizide Er	Glipizide	47	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	14
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	47	suppressed
Glimepiride	Glimepiride	45	14
Sildenafil Citrate	Sildenafil Citrate	45	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Ozempic	Semaglutide	41	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	38	11
Valsartan	Valsartan	38	11
Diazepam	Diazepam	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	16
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	34	34
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Primidone	Primidone	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Tiadylt Er	Diltiazem Hcl	26	11
Xarelto	Rivaroxaban	26	suppressed
Atenolol	Atenolol	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	11
Methotrexate	Methotrexate Sodium	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Desmopressin Acetate	Desmopressin Acetate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Cephalexin	Cephalexin	19	11
Diltiazem 24hr Er	Diltiazem Hcl	19	12
Methylprednisolone	Methylprednisolone	19	18
Mounjaro	Tirzepatide	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Ramipril	Ramipril	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Folic Acid	Folic Acid	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Metronidazole	Metronidazole	17	15
Ondansetron Odt	Ondansetron	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Digoxin	Digoxin	14	suppressed
Estradiol	Estradiol	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Levetiracetam Er	Levetiracetam	13	suppressed
Naproxen	Naproxen	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Topiramate	Topiramate	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Benzonatate	Benzonatate	11	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error